MBX
MBX Biosciences, Inc. Common StockNASDAQHealthcare$32.99+2.17%ClosedMarket Cap: $1.11B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
9
Sales
1
Buy/Sell Ratio
9.00
Total Bought
$1.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Mar 18 | Smither John W | Sell | 0 | $0.00 | 0 | |
| Mon Mar 16 | Hawryluk P. Kent | director, officer: President & CEO | Buy | 18,500 | $28.41 | 486,777 |
| Fri Feb 27 | Hawryluk P. Kent | director, officer: President & CEO | Sell | 28,768 | $16.00 | 728,274 |
| Tue Feb 03 | Azoulay Salomon | officer: Chief Medical Officer | Sell | 70,000 | $39.07 | 70,000 |
| Tue Feb 03 | Azoulay Salomon | officer: Chief Medical Officer | Sell | 15,000 | $0.00 | 15,000 |
| Tue Feb 03 | Bartram Richard | officer: Chief Financial Officer | Sell | 70,000 | $39.07 | 70,000 |
| Tue Feb 03 | Bartram Richard | officer: Chief Financial Officer | Sell | 15,000 | $0.00 | 15,000 |
| Tue Feb 03 | Hawryluk P. Kent | director, officer: President & CEO | Sell | 35,250 | $0.00 | 699,506 |
| Tue Feb 03 | Hawryluk P. Kent | director, officer: President & CEO | Sell | 164,500 | $39.07 | 164,500 |